Isa Odidi
Chief Executive Officer bij INTELLIPHARMACEUTICS INTERNATIONAL INC.
Vermogen: - $ op 31-03-2024
Profiel
Isa Odidi is the founder of Intellipharmaceutics International, Inc., which was founded in 1998.
He is currently the Chairman of Smart Pharmaceutical Shanghai Ltd.
and a Professor at Toronto Institute of Pharmaceutical Technology.
In the past, he served as the Chief Executive Officer of IntelliPharmaCeutics Ltd.
and as the VP-Drug Development & New Technologies Research at Biovail Corp.
from 1995 to 1998.
Dr. Odidi has an MBA from Rotman School of Management, graduate and doctorate degrees from the University of London, and an undergraduate degree from Ahmadu Bello University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 05-02-2024 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Isa Odidi
| Bedrijven | Functie | Begin |
|---|---|---|
| INTELLIPHARMACEUTICS INTERNATIONAL INC. | Chief Executive Officer | 01-01-1998 |
| Toronto Institute of Pharmaceutical Technology | Corporate Officer/Principal | - |
| Smart Pharmaceutical Shanghai Ltd. | Chairman | - |
Eerdere bekende functies van Isa Odidi
| Bedrijven | Functie | Einde |
|---|---|---|
IntelliPharmaCeutics Ltd.
 IntelliPharmaCeutics Ltd. Pharmaceuticals: MajorHealth Technology IntelliPharmaCeutics Ltd. designs and develops controlled release drugs. The firm engages in research, development, licensing & marketing of new and generic controlled release pharmaceutical products. It provides life cycle management or new chemical entity delivery system solutions for small molecule drugs through its patented HYPERMATRIX technology. It was founded in 1998 and is headquartered in Toronto, Canada. | President | 27-10-2009 |
Biovail Corp.
 Biovail Corp. Pharmaceuticals: MajorHealth Technology Biovail Corp. develops and manufactures pharmaceutical products. The company provides different types of products which include Wellbutrin SR, Retavase, Zyban and Tiazac XC in Canada and Zovirax Ointment and Zovirax Cream in the United States. Its products are used for cardiovascular disease, central nervous system disorders, pain management and other niche areas. It was founded on March 29, 1994 and is headquartered in Mississauga, Canada. | Corporate Officer/Principal | 01-01-1998 |
Opleiding van Isa Odidi
| Rotman School of Management | Masters Business Admin |
| University of London | Doctorate Degree |
| Ahmadu Bello University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| INTELLIPHARMACEUTICS INTERNATIONAL INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Biovail Corp.
Biovail Corp. Pharmaceuticals: MajorHealth Technology Biovail Corp. develops and manufactures pharmaceutical products. The company provides different types of products which include Wellbutrin SR, Retavase, Zyban and Tiazac XC in Canada and Zovirax Ointment and Zovirax Cream in the United States. Its products are used for cardiovascular disease, central nervous system disorders, pain management and other niche areas. It was founded on March 29, 1994 and is headquartered in Mississauga, Canada. | Health Technology |
IntelliPharmaCeutics Ltd.
IntelliPharmaCeutics Ltd. Pharmaceuticals: MajorHealth Technology IntelliPharmaCeutics Ltd. designs and develops controlled release drugs. The firm engages in research, development, licensing & marketing of new and generic controlled release pharmaceutical products. It provides life cycle management or new chemical entity delivery system solutions for small molecule drugs through its patented HYPERMATRIX technology. It was founded in 1998 and is headquartered in Toronto, Canada. | Health Technology |
| Smart Pharmaceutical Shanghai Ltd. |
